Despite its government spending more than any other on health care both per capita and as a percentage of GDP, spending over $4.5 trillion in 2022, the United States has the lowest life expectancy at ...

New drug discovery is extremely inefficient. Estimates of the average R&D cost per new drug are less than $1 billion to more ...

It was one of those conversations you never forget. We were discussing – of all things – the Covid injections, and I was questioning the early ‘safe and effective’ claims put forward by the pharmaceut ...

Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...

California Gov. Gavin Newsom will soon decide whether the most populous U.S. state will join 25 others in regulating the ...

Effective provider segmentation can make or break a new drug launch, and can also improve the lifecycle of existing portfolio ...

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, ...

Yakubison discusses his role at Merck & Co., Inc., Rahway, NJ, USA (hereinafter “MSD”), the evolution of pharmaceutical ...

Clarity Pharmaceuticals Ltd ( ASX:CU6 ) is possibly approaching a major achievement in its business, so we would ...

For the third year in a row, Cognizant has signed up to the Pharma Industry Awards 2024 as impact ambassador. The impact ambassador programme drives engagement with thought leadership initiatives ...